Human pancreatic cells with a typical ductal phenotype and potential to proliferate can be obtained in vitro, but the differentiation capacity of these putative human pancreatic stem cells remains to be documented. We investigated the protein and mRNA expression of insulin promoter factor 1 (IPF-1) (or pancreas/duodenal homeobox 1), a transcription factor critical for pancreatic development and endocrine cell neogenesis, in human pancreatic ductal cells derived from cultured exocrine tissue. In vitro, exocrine cells rapidly adhered (within 12 h) and were de-/transdifferentiated to ductal cells after 3 days with a dramatic loss of amylase protein (n = 4, 92 ± 3.3%, P < 0.05 vs. day 1) and a simultaneous increase of ductal cytokeratin 19 protein (n = 4, 3.4-fold on day 3 and 7-fold on day 9, P < 0.05 vs. day 1). IPF-1 protein and mRNA levels were low to undetectable in exocrine preparations before culture. After 2 days of culture, a 3.2-fold increase in IPF-1 protein was observed, corresponding to the characteristic 46-kDa protein in Western blots. Reverse transcriptase-polymerase chain reaction confirmed a 10.5-fold increase in IPF-1 mRNA levels after 3 days of culture (n = 5, P < 0.001 vs. day 1). Double immunocytochemistry showed direct evidence that IPF-1 appeared during culture in these exocrine-derived ductal cells (cytokeratin 7-positive) and was not merely in contaminating endocrine cells (chromogranin A-positive).
D
uring development, the pancreas is derived from a common endodermal cell lineage (1) . The proliferation and subsequent differentiation of the embryonic pancreatic epithelium gives rise to the three pancreatic cell types (endocrine, acinar, and ductal cells) (2) . In both rodents and humans, immunohistochemical studies have demonstrated that this common differentiating progenitor cell is ductal in phenotype (cytokeratin -or CK19-positive) (3, 4) . In the adult pancreas, endocrine cell formation from ductal epithelial cells can be observed both in experimental models of pancreatic regeneration (5) and in various clinical pathologies (6) . Islet differentiation from murine pancreatic ductal stem cells in vitro has recently been achieved (7) . Human pancreatic cells with a ductal phenotype and potential to proliferate can be obtained ex vivo by culturing exocrine tissue obtained from healthy adult donors (8, 9) . Although human ductal cell differentiation has been suggested by indirect morphological observations (10) , the endocrine differentiation capacity of these potential human pancreatic stem cells remains to be documented.
Insulin promoter factor 1 (IPF-1) (or pancreas/duodenal homeobox 1 [PDX-1]/somatostatin transactivating factor 1/islet duodenal homeobox 1) is a homeodomain protein mainly restricted to differentiated ␤-cells in the adult pancreas (11) , which regulates the expression of several ␤-specific genes (12) . IPF-1/PDX-1 expression is conserved in highly expanded human ␤-cells that have lost insulin expression (13) . During pancreatic ontogeny, expression of IPF-1 appears essential for the formation of both the endocrine and exocrine pancreas in mice (14) and in humans (15) , resulting in pancreatic agenesis in its absence. IPF-1 is also significantly reexpressed within proliferating ductal cells (16, 17) during pancreatic regeneration (18) (19) (20) (21) . IPF-1 may be a marker of cells that regain their pluripotency to differentiate into any pancreatic cell type (21) . Because IPF-1 expression in adult ductal cells appears to be a prerequisite for their differentiation into ␤-cells in animal models (18) , the expression of IPF-1 in human ductal cells obtained in culture may provide further evidence of their differentiation potential, suggesting that these cells may be endocrine precursor candidates. The goal of this study was to demonstrate that a population of human IPF-1/PDX-1 non-␤-cells can be obtained ex vivo from the abundant exocrine tissue, which may prove to function as pancreatic stem cells in the adult human pancreas.
RESEARCH DESIGN AND METHODS
All products were purchased from Life Technologies (Paisley, Scotland) unless specified. Characteristics and origin of antibodies used in immunohistochemistry, Western blot, and slot blot studies are detailed in Table 1 Human ductal cells. Human cells with a ductal phenotype were obtained in culture from exocrine-enriched pancreatic preparations. Human pancreases (n = 12) were harvested from adult brain-dead donors (mean age 36.7 ± 8 years) in agreement with French regulations and with the ethical committee of our institution. Pancreases were predistended on the back table with 80 ml of a cold collagenase solution (0.5 mg/ml Liberase or Collagenase type P; Roche Diagnostics, Meylan, France) diluted in Hanks' balanced salt solution. After 3 ± 2 h of cold storage in Eurocollins solution (Fresenius, Hamburg, Germany), pancreases were dissociated using the automated method of Ricordi et al. (22) with few modifications (23) . After selection of optimal separation densities with a multilayer test gradient (23) , islet purification was obtained in a discontinuous EuroFicoll or Histopaque gradient with a cell separator (Cobe 2991; Cobe BCT, Lakewood, CO).
The exocrine fraction was recovered in the pellet, washed three-fold in Hanks' solution, and cultured in (80 µl of pellet/75-cm 2 dish) Dulbecco's minimum essential medium (3 g/l glucose) containing 10% fetal calf serum (Euro Bio Laboratories, Les Ulis, France), 1% insulin transferrin selenium (ITS, Sigma-Aldrich), and 50 µg/ml Geneticin (G418; Sigma-Aldrich) to limit fibroblast overgrowth (9) . After 12 h of attachment and every 2-3 days thereafter, the culture media were changed; monolayer cultures were maintained for 2 weeks. Cell proliferation. For cell proliferation, estimated in three exocrine preparations, 1 µCi/ml of tritiated thymidine (ICN Pharmaceuticals, Orsay, France) was added to the culture medium for 8 h in triplicate at day 1, 1.5, 2, 3, 4, 6, and 10. Cells were washed, precipitated with trichloroacetic acid (5%), sonicated, and dissolved in sodium hydroxide (0.5 mol/l). DNA was measured in duplicate in each well using the Picogreen DNA quantitative reagent (Molecular Probes, Leiden, the Netherlands) (24) . Results were confirmed in additional experiments (n = 2) with Cell Titer 96 (Promega, Madison, WI), a colorimetric proliferation assay that uses 3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2 H-tetrazolium (MTS). RNA. For reverse transcriptase (RT)-polymerase chain reaction (PCR), total RNAs were isolated with RNAzol B (Bioprobe Systems, Montreuil, France) and quantified by spectrophotometry (260 nm). The cDNAs were synthesized from 2 µg DNA-free total RNA with oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers and RT (Moloney murine leukemia virus [M-MLV]). PCR was performed with a 1-µl aliquot of RT reaction product in the presence of 200 mmol/l dNTP, 1.5 mmol/l MgCl 2 , 25 pmol/l (IPF-1) or 5 pmol/l (␤-actin) sense and antisense primers, and 5 U AmpliTaq DNA polymerase (PE-Applied Biosystems, Warrington, U.K.). Primer sets (PE-Applied Biosystems) included the IPF-1 primers (product size 262 bp) 5Ј-CCCATGGATGAAGTCTACC-3Ј and 5Ј-GTCCTCCTCCTTTTTC CAC-3Ј, the insulin primers (product size 260 bp) 5Ј-TGTGAACCAACACCT GTG-3Ј and 5Ј-CGTCTAGTTGCAGTAGT-3Ј; and the ␤-actin primers (314 bp product size) 5Ј-ATCATGTTTGAGACCTCCAA-3Ј and 5Ј-CATCTCTTGCTC GAAGTC CA-3Ј. PCR was carried out in a thermal cycler (2400, PE-Applied Biosystems) with 35 cycles for IPF-1 (94°C, 1 min/52°C, 1 min/72°C, 1 min) and with 27 cycles for insulin (94°C, 30 s/53°C, 1 min/75°C, 30 s). To measure insulin, the RT reaction products of control islets were diluted to avoid saturation. All PCR products were electrophoresed in a 2% agarose gel, and band intensity was scanned with a digital integration charged-coupled device camera (COHU 4912). Band intensities, expressed in arbitrary units, were quantitated with GelAnalysts 3.01 FR software (GreyStone-Iconix) for a PowerPC Macintosh. Specific product expression was normalized for internal control ␤-actin levels. Protein. For slot blotting and Western blotting techniques, cultured exocrine cells were trypsinized (0.025% trypsin-5 mmol/l EDTA) in Ca 2+ /Mg 2+ free Hanks' solution (Sigma-Aldrich) and washed in culture media. Cells were homogenized on ice in phosphate-buffered saline (PBS) supplemented with 0.25 mol/l sucrose (Euromedex, Souffelweyersheim, France) and lysed by ultrasonication (Bioblock, Illkirch, France). Protein concentrations were measured with an bicinchoninic acid protein assay reagent (Pierce, Rockford, IL). For slot blots, total proteins (25 µg) were deposited on nitrocellulose membranes (Sigma-Aldrich) using Slot Blot Filtration Manifolds (Amersham). Membranes were blocked in 5% nonfat milk in PBS (blocking solution) overnight at 4°C and incubated with antibodies (amylase, chromogranin A, IPF-1, and CK19; Table 1 ) in diluted blocking solution (1:10) for 2 h. Membranes were washed two times for 15 min in PBS and incubated for 1 h with horseradish peroxidase-labeled secondary antibody that was diluted (1:2,000) in a prediluted (1:10) blocking solution. After three 15-min washes in PBS, binding of the antibody was visualized with an enhanced chemiluminescence reagent (ECL kit; Amersham). A kinetic slot blot study for IPF-1 (n = 2) and ␤-actin (n = 3) was repeated on additional preparations using the more sensitive detection system ECL Plus (Amersham) and a phosphoimager (Storm 860; Molecular Dynamics, Sunnyvale, CA). Spot intensities either were quantitated as above and expressed in arbitrary units or were quantitated with Image Quant 5.0 (Molecular Dynamics) and expressed in arbitrary (phosphoimager) units. For Western blots, total protein (50 µg) was separated by electrophoresis on a 10% sodium dodecyl sulfate polyacrylamide gel and blotted onto polyvinylidene difluoride membranes (Amersham). Blocking membranes and immunochemiluminescence were performed as described above. Immunohistochemistry. Immunohistochemistry was performed on cells fixed in cold 80% ethanol (-20°C, 10 min), on cell cytospins fixed in 1% paraformaldehyde (PFA), or on paraffin sections of lean (BMI 24.7 ± 3.6 kg/m 2 ) nondiabetic (HbA 1c 4.9 ± 0.3%) pancreatic tissue (n = 29) fixed immediately after harvesting in 10% formalin (Sigma-Aldrich) or PFA. We also examined surgical specimens obtained from patients with multiple endocrine neoplasia who had a pancreatic endocrine tumor(s) with foci of nesidioblastosis in the neighboring pancreas (n = 3) or sporadic diffuse nesidioblastosis causing overt hyperinsulinism (n = 2). The detailed clinical characteristics of these patients have been previously reported (25) . Table 1 dard permeabilization (0.01% saponin, 10 min) and proteinase-K pretreatment. In addition, IPF-1 antibodies were diluted in 1% bovine serum albumin (Sigma-Aldrich) containing 0.01% saponin (or 0.1% Triton-X-100) (C. Wright, personal communication). Controls included replacing the primary antibody with PBS containing bovine serum albumin (1%). All washes were performed with 0.05 mol/l Tris-HCl-0.15 mol/l NaCl (pH 7.6). Nuclei were counterstained with Carazzi's hematoxylin. Apoptosis. Caspase activity (cytostolic aspartate-specific protease) was measured fluorometrically using the fluorogenic substrate N-acetyl-Asp-Glu-Val-Asp-(7-amino-4-trifluoromethyl coumarin) (DEVD-AFC). Cells were pelleted and lysed in 100 µl buffer (20 mmol/l Tris HCl, pH 7.5, 50 mmol/l NaCl, 5 mmol/l EGTA, 2 mmol/l MgCl 2 , 1.25 dithiothreitol, 1.25 mmol/l phenylmethylsulfonyl fluoride, 1.25 µg/ml aprotinin, and 1.25 µg/ml pepstatin A). A fraction of cell lysate was incubated in the presence on DEVD-AFC (20 mmol/l) for 1 h at 37°C. The reaction was stopped with 0.2 mol/l glycine, pH 2.8. The release of AFC was measured using a fluorophotometer equipped with a microtiter plate accessory (Fluorocount; Packard, France) using an excitation wavelength of 400 nm and emission wavelength of 505 nm. As a positive control for apoptosis, cells were stimulated with 1 µmol/l camptothecin (CAM) for 4 h at 37°C. In the same fraction, protein content was determined using an NanoOrange protein quantitation kit (Molecular Probes). Caspase 3 levels were expressed with reference to protein levels (nanomoles per milligram). Both annexin V/propidium iodide (PI) and amylase/Hoechst 33258 (SigmaAldrich) were evaluated in PFA-fixed cytospin preparations (n = 2) after day 0, 0.5, 1, 1.5, 2, 3, 5, 7, and 9 of culture. Annexin V, an early indicator of apoptosis, was detected after fixation with an ApopNexin kit (Oncor, Gaithersburg, MD) as described. Nuclear signs of apoptosis were visualized with PI (1 µg/ml for 5 min). Positive control CAM-treated apoptotic cell preparations were used to validate this assay.
Amylase / Hoechst 33258: Specific acinar cell apoptosis was evaluated after immunolabeling for anti-amylase, visualized with biotinylated goat anti-rabbit antibody (Kirkegaard & Perry Laboratories) and streptavidin-fluorescein isothiocyanate (FITC) (Sigma Aldrich). Nuclear apoptotic alterations were visualized with Hoechst 33258 (5 µg/ml, 10 min, 37°C). Coverslips were mounted with DABCO (1,4-diazabicyclooctane) anti-fade (Sigma-Aldrich). To determine if nonacinar cells selectively adhered, "plating efficiency" was calculated before and after 12 h of culture in two preparations by counting the number of amylase-positive cells in proportion to the total number of cells (nuclei).
Growth fraction: The number of acinar cells in the growth fraction was determined by double labeling cell cytospins after 12 h and 2 days of culture with amylase and Ki-67, which labels cells in all phases of the growth cycle except cells in G 0 . A minimum of 800 cells were counted per manipulation per time point for the preparations (n = 2). For confocal microscopy (Leica TCS-NT, Rueil-Malmaison, France), cells were grown on Lab-tek coverslip chambers (Nalgene; Nunc International), which were fixed and immunolabeled for amylase and Ki-67 and revealed as above with rhodamine (red) and FITC (green), respectively, confirming the specific identity of cells in the growth fraction. Optical sections (1 µm) were acquired at 1-to 2-µm intervals through the cell monolayers. Statistical analysis. Results of continuous variables are expressed as means ± SE. The differences between groups were analyzed with the bilateral paired Student's t test and considered significant when P was <0.05.
RESULTS
We examined IPF-1 immunoreactivity in more than 34 pancreases including pathological specimens demonstrating clinically elevated levels of islet neogenesis (n = 5 cases of adult nesidioblastosis). Immunolabeling for insulin and CK19 ( Fig. 1A and C) emphasized islets (red) and scattered ductal cells (brown) in pancreatic sections. In nonpathological specimens (n = 29), both IPF-1 antibodies were specific for islets (Fig. 1B) , demonstrating a major cytoplasmic and minor diffuse nuclear localization (Fig. 1B inset) . Only some islet nuclei showed intense IPF-1 labeling. IPF-1 + cells were detectable in the majority (93 ± 2%) of normal ducts (≥20 main/interlobular/large intralobular ductal structures assessed per section; considered positive when there was >1 IPF-1 cell per duct). Ductal IPF-1 labeling was fainter than IPF-1 immunolabeling in adjacent islets (data not shown). Figure  1C shows a pathological specimen with clinical nesidioblastosis in which insulin-positive cells appear to bud from CK19 + ductal structures; double CK19/insulin immunolabeled cells can be observed (Fig. 1E) . IPF-1 immunostaining in ducts ( Fig. 1D and F) appeared intensely, comparable to labeling in islets, with a pronounced nuclear and cytoplasmic localization (Fig. 1F inset) . The majority of these intense IPF-1 + cells in the ductal compartment showed no immunoreactivity for insulin (data not shown).
Cultured human exocrine clusters adhered after 12 h of culture and spread out progressively, forming monolayer cultures. Proliferation determined by [ 3 H]thymidine incorporation increased immediately, peaking after 3 days and then slowly dropping off; [ 3 H]thymidine incorporation in counts per minute per microgram DNA ϫ 10 3 ± SE (n = 3) was as follows: 40.5 ± 8.7 (day 1), 79.3 ± 24.2 (day 1.5), 83.7 ± 12.8 (day 2), 95.4 ± 5.4 (day 3), 82.1 ± 5.0 (day 4), 42.9 ± 21.5 (day 6), and 68.5 ± 5.1 (day 10). Proliferation levels were subsequently confirmed in two additional preparations, with the metabolic indicator MTS (Fig. 5 ) demonstrating a rapid increase that leveled off at 5-7 days corresponding to cell confluence. DNA and protein levels paralleled [ 3 H]thymidine proliferation levels. Figure 2 demonstrates the phenotypic transition of cultures determined in slot blots using 25 µg total proteins from cultures. Proteins have been expressed in arbitrary integration units generated after digital scanning and analysis of spot intensities. Consistent protein loading was confirmed in three preparations ( Fig. 2A inset) by measuring ␤-actin levels between wells; no statistically significant differences were established throughout the culture duration.
After isolation, exocrine preparations (n = 4) expressed high levels of amylase protein, whereas the expression of ductal (CK19) and endocrine (chromogranin A) proteins were low ( Fig. 2A ). An extensive reduction in amylase protein was observed after 1 day of culture (n = 4, 92% ± 3.3, P < 0.05 vs. day 1), and levels became progressively undetectable in prolonged culture (day 6). A major increase of the ductal marker (CK19) occurred simultaneously (n = 4, 3.4-fold on day 3, 4.5-fold on day 6, and 7-fold on day 9, P < 0.05 vs. day 1). Slot blots demonstrated that IPF-1 protein was present at minute levels in exocrine preparations after isolation (Fig. 2B) and increased during culture, remaining elevated. Western blotting (Fig. 2C) , representative of five human pancreases, revealed that the characteristic 46-kDa IPF-1 band was weak to undetectable immediately after exocrine cell isolation (day 0) and intensified during the culture. Western blot results were confirmed with two different IPF-1 antibodies to the COOH-terminal and NH 2 -terminal domain. Using the more sensitive ECL Plus and a phosphoimager, a more precise kinetic study (Fig. 2D) pinpointed that this augmentation in IPF-1 protein (3.2-fold) was rapid within the first 2 days of culture. Mean arbitrary units of preparations (n = 2) were as follows: 1,272,045 (day 0), 1,115,496 (12 h), 1,816,780 (day 1), 2,362,663 (day 1.5), 3,552,748 (day 2), 2,697,442 (day 3), 2,497,451 (day 5), 2,587,554 (day 7), and 3,133,067 (day 9).
IPF-1 mRNA expression was determined in cultured exocrine preparations (n = 5) normalized for ␤-actin expression (Fig. 3) . The mean expression of IPF-1/␤-actin in Fig. 3B demonstrated a slight expression before culture that rapidly increased 10.5-fold after 3 days (n = 5, P < 0.001 vs. day 1) and remained elevated 8-fold after 1 week and 7-fold after 2 weeks compared with day 1 (P = 0.08 vs. day 1; P < 0.001 vs. day 0). In addition, insulin mRNA was determined in exocrine preparations to control for the contaminating endocrine population during culture (Fig. 3C) . Islets (n = 4, 71 ± 6% pure) were used as a positive control. Insulin/␤-actin mRNA levels in exocrine cultures remained low, i.e., between 7% (day 0) and 2.5% (days 3 and 7) of levels in islets (note that 0.5 µl and not 1 µl of RT reaction product was used to determine insulin in islets to avoid saturation). No statistically significant differences were observed among day 0, 3, or 7.
Immunohistochemistry (Fig. 4) 
E, arrowheads). In nesidioblastosis (D), IPF-1 (AEC, red) is intensely expressed in islets and ductal cells-the latter in both the cytoplasmic and nuclear compartment (F). Centroacinar cells were often labeled (D and F).
of ductal antigen labeling ( Fig. 4A, CK19 ; CK7 and carbohydrate antigen 19-9, data not shown). Insulin was always negative in cultured exocrine preparations; we therefore used the neuroendocrine marker chromogranin A to evaluate the con- (n = 2, 59 ± 1% in triplicate) of total cells were amylase positive at day 0 (i.e., 41% nonacinar), and this percentage remained identical after 12 h. Apoptosis was monitored by three means: caspase 3 levels in attached cultures (n = 2), annexin V immunolabeling with nuclear PI, and anti-amylase/Hoechst 33258 (n = 2 preparations at day 0, 0.5, 1, 2, 1.5, 2, 5, 7, and 9). Although DNA and total protein levels increased, caspase 3 levels measured on cell lysates and expressed per milligram of protein remained constant and relatively low compared with positive control CAM-treated cultured cells (Fig. 5) . Annexin V binding to the membrane phospholipid phosphatidylserine, an early apoptotic marker, was elevated (green FITC plasma membrane) in CAM-treated PFA-fixed cells before signs of nuclear fragmentation (Fig. 6B, inset) . Annexin V binding fluorescence was virtually absent in exocrine cultures, especially during the major phenotypic change (day 3). At day 5, a small number of cells in cultures had half-moon-shaped nuclei, indicative of the apoptotic process; however, they remained annexin V negative (annexin V/PI, Fig. 6B ). In particular, amylase-positive acinar cells did not show signs of apoptosis in this model (Fig. 6C and D) . . Confocal microscopy of an optical section of exocrine monolayer preparations (Fig. 6E) confirmed that amylase-positive acinar cells (rhodamine, red) were indeed in the growth fraction (nuclear Ki-67, FITC green).
V. GMYR AND ASSOCIATES

FIG. 2. Protein expression of 14-day cultured human exocrine preparations (A and B, mean ± SE of five experiments). Slot blot analysis of 25 µg total protein shows (A) acinar phenotype with anti-amylase (), ductal phenotype with anti-CK19 (ᮀ), endocrine phenotype with anti-chromogranin A (᭺), and (B) anti-IPF-1 (mean ± SE, P < 0.05 vs. day 0). Spot intensities were quantitated in arbitrary integration
DISCUSSION
Tremendous efforts have been devoted to identifying embryonic markers localizing the putative pancreatic stem cell(s) in the ductal epithelium (27) . The role of the transcription factor IPF-1 in islet neogenesis is supported by its enhanced expression in pancreatic ducts (the site of endocrine cell precursors) in various models of pancreatic regeneration (16,18,20,21) . ductal cells supports the hypothesis that all adult ductal cells can regain pluripotency (i.e., stem cell capacity) by undergoing rapid cycling (28) . The decisive role of IPF-1/PDX-1 in the endocrine differentiation of digestive endodermal cells was recently confirmed in the liver (29) . We investigated whether the expression of IPF-1 could be obtained in vitro in human pancreatic ductal cells obtained in culture from exocrine cell preparations. The switch of cultured exocrine cell preparations to a ductal phenotype has been well characterized in diverse species (8, 9, 30, 31) , but the exact mechanism involved remains controversial. Duct ligation in the rat is followed by the simultaneous apoptotic deletion of acinar cells and proliferation of duct cells (32) . When plating mouse acinar cells, Logsdon and Williams (33) have also shown a substantial loss of exocrine tissue (DNA and protein) preceding cell proliferation. In this study, a rapid increase in cell proliferation, DNA, and protein levels immediately after cell attachment (12 h) paralleled the initial increase in ductal cell markers and the drop in amylase levels. Selective attachment of ductal cells and death and/or apoptosis of acinar cells cannot explain these findings in our model because the proportion of amylase-positive cells initially present in preparations remained identical after 12 h of culture, when dishes were washed of unattached cells. Alternatively, this rapid loss of amylase may have been due to a diminution in amylase protein levels within the acinar cells. None of the three methods used to evaluate apoptosis, including early and late markers (caspase 3, annexin V, PI, and Hoechst 33258), detected increasing levels of apoptosis during the phenotypic switch (day 3). On the contrary, the presence of Ki-67/amylase-positive cells early in cultures attests to their proliferation potential and confirms that the phenotypic switch comes with cell proliferation as previously demonstrated in other models (21, 34) . The elevated Ki-67 levels early on in cultures may be related to the nonspecificity of this maker, labeling a nuclear antigen in all phases of the cell cycle except G 0 . In our study, the intensity of Ki-67 labeling between cells was heterogeneous, as shown by Sasaki et al. (35) , who reported that the antigenic expression increases with cell cycle progression, rising during the latter half of the S phase. In particular, no sign of apoptosis was detected in acinar cells in the time frame in which amylase levels dropped off and ductal antigens initially increased. The appearance of a small number of half-moon-shaped nuclei (PI staining) was observed only after 5 days of culture after the major phenotypic switch. The absence of significant apoptosis in these cultures and the presence of elevated proliferation levels converge to suggest that acinar cells are actually dedifferentiating to a ductal cell phenotype, albeit simultaneously with the rapid growth of preexisting CK19 + cells. These exocrine-derived ductal cells initially expressed lowto-undetectable levels of the IPF-1 protein and low levels of IPF-1 mRNA that rapidly increased during culture. The 46-kDa band, characteristic of IPF-1, was confirmed with 2 IPF-1 antibodies. To exclude the detection by these sensitive techniques of IPF-1 derived from the minute percentage of contaminating endocrine cells, we simultaneously quantified insulin mRNA. Initially, only slightly detectable compared with purified islets, insulin mRNA levels remained unchanged during culture. The contribution of these rare insulin-positive cells can therefore hardly account for the large increase in IPF-1 expression that we observed. Highly expanded human IPF-1 + ␤-cells have recently been reported to lose insulin gene expression (13) , but in this study, insulin mRNA levels remained unchanged throughout the culture period.
Immunohistochemistry with 2 IPF-1 antibodies localized IPF-1 expression to ductal cells (CK7   +   ) . Only a few endocrine cells were present (Fig. 4 , chromogranin A positive, IPF-1 + /CK7 -). Using pan-neuroendocrine markers including chromogranin A and synaptophysin, we estimated that 4.7 ± 1.8% of total cells were endocrine in the initial preparation, and 3.5 ± 0.8% of cells were endocrine after 7 days of culture (results not shown); albeit, only a proportion of these neuroendocrine cells were ␤-cells (insulin immunolabeling was routinely negative in exocrine cultures) and thus potentially IPF-1 positive. The intense IPF-1 and CK19 (CK7) immunolabeling and the discrepancy between this slight (<5%) endocrine contamination in exocrine cultures further corroborate that IPF-1 was not merely derived from contaminating CK19
-␤-cells. Double immunolabeling studies of IPF-1 and synaptophysin (data not shown) reconfirmed this fact. An apparent discrepancy exists between the cytokeratin peaking at day 9 and the fact that there were no further changes in IPF-1 after day 3 either in protein or mRNA. The major phenotypic switch occurred up to 5 days of culture, and because DNA and protein levels both decreased by 5-9 days, it would thus appear that the expression of CK19 per cell increased over time. Incidentally, this decrease in DNA and protein levels after 9 days of culture corroborates a decrease in cell number after confluence (i.e., after 5 days of culture). Although 7-day cell preparations looked morphologically unimpaired (Fig. 4) , it is possible that after confluence, some cells detached, a small population of cells may have died of apoptosis (as mentioned in Fig. 6 [half-moon-shaped nuclei] indicative of the apoptosis process), and finally, morphologically, cells may have spread out.
The cytoplasmic IPF-1 labeling observed in immunohistochemistry with human tissue may appear to contradict published nuclear PDX-1 localization in rat and mouse islets. On the contrary, Macfarlane et al. (36) recently demonstrated that human islets contain an inactive 31-kDa cytoplasmic IPF-1 form that, upon stimulation with glucose or chemical stress, translocates to the nucleus, representing the active IPF-1 protein at 46 kDa in Western blots. To our knowledge, no literature on immunohistochemistry has been published about human pancreatic sections confirming the presence of both forms in human islets. Accordingly, testing the NH 2 -terminal PDX-1 antibody used in the study by Macfarlane et al. (36) as well as the Kajimoto's COOH-terminal PDX-1 antibody, we confirmed a nuclear and major cytoplasmic localization of IPF-1 in human islets. Western blots of purified total human islet protein extracts demonstrated both a 31-kDa and a 46-kDa protein form (data not shown) using the NH 2 -terminal PDX-1 antibody. Protein extracts of cultured human exocrine preparations demonstrated the major 46-kDa band and a minor undetectable cytoplasmic 31-kDa band. IPF-1 immunolabeling required specific conditions including proteinase K and saponin in the antibody diluant, which created both cytoplasmic and nuclear IPF-1 labeling in human pancreatic sections and in PFA-fixed cell cytospins. These conditions, confirmed with three additional detection systems, gave an intense nuclear IPF-1 labeling of cultured paraffin-embedded human islets as previously reported (13) (data not shown). In contrast, exocrine-derived ductal cells demonstrated both nuclear and cytoplasmic IPF-1 labeling, similar to ductal cells in pancreatic sections from patients with nesidioblastosis, a clinical feature similar to experimental pancreatic regeneration. This differential IPF-1 expression in islets and ductal cells has been recently endorsed by another team (37) and requires further elaboration.
Unlike the IPF-1 + but CK19 -cells demonstrated by Beattie et al. (13) , which were endocrine in origin, the majority of cells in these exocrine-derived cultures displayed a typical ductal phenotype (positive for CK19, CK7, and carbohydrate 19-9 [data not shown]) and were simultaneously IPF-1 positive. The initial cultures described by Beattie et al. were insulin and IPF-1 positive, very unlike ours, implying that the IPF-1 + cells in their study were dedifferentiated ␤-cells.
Thus, we have shown that the rapid de-/transdifferentiation of exocrine cells cultured in vitro is associated with an increase in ductal markers and in the transcription factor IPF-1 on a protein (slot blot, Western blot, and immunohistochemistry) and mRNA level. Our results may endorse the old hypothesis of the transdifferentiation of acinar cells into endocrine islets (38, 39) . Pancreatic exocrine cells transiently coexpress amylase and IPF-1 during development (40) . In adult differentiated acinar cells, IPF-1 expression remains controversial (2, (41) (42) (43) . A transient increase in IPF-1 immunostaining in the nuclei and cytoplasm of murine acini was reported 24 h after streptozotocin treatment (19) , and low levels of IPF-1 mRNA and protein have also been detected in rat and murine exocrine cell lines (266-6, C5-2B, AR42J) (43) . In fact, IPF-1 can activate the transcriptional enhancer of the elastase I gene in an acinar cell-specific trimer complex (IPF1-PBX1b-MRG1) (43) . To date, no report details IPF-1 expression in the human adult exocrine pancreas, with the exception of an abstract (37) , and this merits further investigation. In this study, the inevitable contaminating ␤-cells (<5%) account for the IPF-1 (mRNA and protein) initially detected in isolated exocrine tissue. However, in situ hybridization techniques could rule out whether human amylase-positive acinar cells also express low levels of IPF-1 mRNA, as suggested in other species (42, 43) . In addition to the reexpression of IPF-1 during this dedifferentiation, we are investigating the presence of other endocrine/exocrine-specific genes to further define the differentiation state of these exocrine-derived ductal cells (17) . The in vivo replacement of exocrine acini by ductal tubular complexes via de-/transdifferentiation has been clearly depicted in both animal and clinical models (44, 45) . IPF-1 immunoreactivity in these ductal tubular complexes in patients with pancreatitis awaits confirmation. In light of our results, the contribution of such exocrine-derived (CK19 + , IPF-1 + ) ductal cells to pancreatic endocrine remodeling in vivo merits reconsideration.
In summary, we describe in this study converging evidence, both on the molecular and protein level, that human pancreatic cells with a typical ductal phenotype derived from cultured exocrine preparations can reexpress IPF-1. Confirming recent reports in vivo, we therefore have shown that reexpression of IPF-1 can be obtained ex vivo from exocrine preparations isolated from healthy human donors. In animal models of regeneration, IPF-1 reexpression in ductal cells is considered to be a prerequisite to their differentiation, suggesting that these ductal cells obtained from culturing pancreatic exocrine preparations may indeed serve as endocrine precursors. The similar intense labeling of IPF-1 in pancreatic ductal structures of patients with documented nesidioblastosis and overt hyperinsulinism further supports the clinical relevance of this hypothesis. If the differentiation potential of these putative pancreatic stem cells is confirmed, as recently suggested (10, 46) , this model may have immediate clinical repercussions. Indeed, exocrine cells are easily obtained from human pancreases and may prove to be a particularly abundant source of ␤-cell precursors for allogenic cell therapy in type 1 diabetes. Furthermore, because partial pancreatectomy can be performed with little morbidity (47) , this method may also allow the isolation of immunologically privileged cells obtained from living related donors. This abundant source of pancreatic stem cells could even offer a realistic perspective for autologous somatic cell therapy of type 1 diabetes (7).
